Tag: report

PALM BEACH, Fla., July 16, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Worldwide, there is a growing demand for cryptocurrency payments applications. A report from Grand View Research projected that the global cryptocurrency payment apps market size was estimated at USD 556.9 million in 2024 and is projected to reach USD 2,404.1 million by 2033, growing at a CAGR of 17.8% from 2025 to 2033. The emergence of Web3 and blockchain technology created the need for cryptocurrency payment apps to enable individuals to conduct seamless transactions. The report said: “The growing adoption of cryptocurrencies globally is the key driver for the market's expansion. People are encouraged to use cryptocurrency payment platforms owing to the decentralized nature of the blockchain, which eliminates mediators such as banks from the payment processing system. It reduces the processing time and accelerates the transaction speed, consequently adding to the increasing popularity of such platforms. In addition, the growing prevalence of cryptocurrencies as an investment option among millennials is also fueling the growth of the cryptocurrency payment apps industry.” It continued: “One of the most transformative trends in the market is the increasing interoperability between crypto payment platforms and traditional banking systems. Crypto apps now allow users to seamlessly convert digital assets into fiat currencies and vice versa, enabling easier withdrawals, direct-to-bank transfers, and debit card functionalities. This fusion is bridging the gap between old and new financial infrastructures, encouraging a smoother transition for users hesitant to move entirely into decentralized finance (DeFi). Thus, increasing integration of cryptocurrency payment apps with traditional financial systems can be attributed to the market’s growth.” Active companies in the markets this week include Amaze Holdings, Inc. (NYSE American: AMZE), Shopify Inc. (NASDAQ: SHOP), Roblox Corporation (NYSE: RBLX), PayPal Holdings, Inc. (NASDAQ: PYPL), Hut 8 Corp. (NASDAQ: HUT).

NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group," “Aptorum” or the "Company"), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs in oncology  and infectious diseases, and DiamiR Biosciences (“DiamiR”), a developer of proprietary innovative blood-based tests for brain health and other diseases with a CLIA licensed, CAP accredited clinical laboratory in New Haven, CT, today announced that they have entered into a definitive agreement for an all-stock merger transaction, in which DiamiR Biosciences will retain its name and become a wholly-owned subsidiary of Aptorum Group upon consummation of the merger.The combined company expects to remain listed on the Nasdaq Stock Market following the closing of the merger.

Canadian luxury market performance led by Montreal and Calgary as attainable housing prices, measured confidence support sales